Biotech and Pharmaceuticals
Watch live: U.S. health officials hold Covid briefing as cases and hospitalizations soar again
[The stream is slated to start at 10:45 a.m. ET. Please refresh the page if you do not see a player above at that time.] Senior U.S. health officials are holding a Covid-19 press conference for the first time in over a month, as infections and hospitalizations are on the rise as more transmissible omicron […]
Read More
House Democrats to hold hearings on baby formula crisis, introduce bill to beef up FDA inspections
Rep. Rosa DeLauro, D-Conn., left, the House Appropriations Committee chair, and Speaker of the House Nancy Pelosi, D-Calif., confer during a news conference on the House Democrats $28 million emergency spending bill to address the shortage of infant formula in the United States, at the Capitol in Washington, Tuesday, May 17, 2022. J. Scott Applewhite […]
Read More
WHO calls for probe into more than 200 Russian attacks on health facilities in Ukraine
CHERNIHIV, UKRAINE – MAY 09: A healthcare professional searches for medicines and medical equipment in a destroyed hospital as Russian attacks continue in Chernihiv, Ukraine on May 09, 2022. Patients are treated in additional buildings as health services are disrupted due to the destroyed hospitals. (Photo by Abdullah Unver/Anadolu Agency via Getty Images) Anadolu Agency […]
Read More
FDA authorizes Pfizer Covid booster dose for kids ages 5 to 11 years old
A vaccinator draws a Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine in Lansdale, Pennsylvania, U.S., December 5, 2021. Hannah Beier | Reuters The Food and Drug Administration on Tuesday authorized a Pfizer booster dose for children ages 5 through 11 years old. Dr. Peter Marks, head of the FDA division responsible for vaccines, said vaccine effectiveness […]
Read More
Abbott reaches agreement with FDA to reopen baby formula plant to ease nationwide shortage
A woman shops for baby formula at Target in Annapolis, Maryland, on May 16, 2022, as a nationwide shortage of baby formula continues due to supply chain crunches tied to the coronavirus pandemic that have already strained the countrys formula stock, an issue that was further exacerbated by a major product recall in February. Jim […]
Read More
Novavax confident Covid vaccine will receive FDA authorization in June after delays
Novavax is confident its Covid-19 vaccine will receive the endorsement of the Food and Drug Administration’s advisory committee early this summer, executives said this week. The FDA committee is scheduled to meet on June 7 to review Novavax’s submission. An endorsement from the committee, which is made up of independent experts, would mean the drug […]
Read More
U.S. to boost baby formula imports to ease nationwide shortage after Abbott Nutrition recall
Baby formula is offered for sale at a big box store on January 13, 2022 in Chicago, Illinois. Scott Olson | Getty Images The U.S. will increase baby formula imports as part of an effort to ease a nationwide shortage, senior Biden administration officials said on Thursday. The scarcity of formula was triggered in part […]
Read More
U.S. licenses key Covid vaccine technology to WHO so other countries can develop shots
U.S. President Joe Biden delivers remarks on the authorization of the coronavirus disease (COVID-19) vaccine for kids ages 5 to 11, during a speech in the Eisenhower Executive Office Building’s South Court Auditorium at the White House in Washington, November 3, 2021. Evelyn Hockstein | Reuters President Joe Biden on Thursday said the U.S. has […]
Read More
WHO says omicron BA.4 and BA.5 subvariants have spread to over a dozen countries
coronavirus impact business and economy Mf3d | E+ | Getty Images Omicron subvariants BA.4 and BA.5 have been detected in more than a dozen countries, helping fuel sporadic Covid outbreaks across the world, but the heavily mutated strains are still circulating at low levels, the World Health Organization said Wednesday. Less than 700 cases of […]
Read More
J&J names Thibaut Mongon, current consumer health leader, as CEO of new spin-off company
Signage is displayed outside of Johnson & Johnson headquarters in New Brunswick, New Jersey, Aug. 1, 2020. Mark Kauzlarich | Bloomberg | Getty Images Johnson & Johnson on Wednesday announced that the current head and the chief financial officer of its consumer health portfolio will lead the business when it spins off into a separate […]
Read More